Kent Davis has over 20 years of experience in the biopharmaceutical industry including cGMP platform technologies for monoclonal antibodies, bacterial proteins, and live biotherapeutics for Phase I, II, and III clinical trials. His background includes process development, technical transfer, manufacturing, and operations. Kent serves as a subject matter expert in downstream processing techniques, including fermentation harvest (dead-end filtration, TFF, and centrifugation), chromatography, and UF/DF. He helped to pioneer the design and development of sterile/single-use/disposable supplies and associated equipment for use in the manufacturing of a potential commercial product for a patient-specific immunotherapy.
Kent joined List Labs in 2009, and currently directs manufacturing activities including lab support, microbiology, fermentation, purification, and process development teams. He earned his BS in chemical/biochemical engineering from the University of California, Davis.